Android app on Google Play

Cempra (CEMP) Prices 7.25M Common Stock Offering

June 14, 2013 9:31 AM EDT Send to a Friend
Get Alerts CEMP Hot Sheet
Trade CEMP Now!
Join SI Premium – FREE
Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it has priced an underwritten public offering of 7,250,000 shares of its common stock at a price of $7.00 per share for aggregate gross proceeds of $50.8 million. Net proceeds after underwriting discounts and commissions and expenses of the offering are expected to be approximately $47.7 million. The company also has granted the underwriters a 30-day option to purchase up to an additional 1,087,500 shares to cover over-allotments, if any, which would result in additional net proceeds of approximately $7.2 million, if exercised in full. The offering is expected to close on or about June 19, 2013, subject to satisfaction of customary closing conditions.

Barclays, Stifel and Cowen and Company are acting as joint book-running managers for the offering. Needham & Company and SunTrust Robinson Humphrey are acting as co-managers.




You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Related Entities

Needham & Company, SunTrust Robinson Humphrey, Barclays, Cowen & Co

Add Your Comment